Theratechnologies to Present at Upcoming Investor Conferences in September
Theratechnologies, a biopharmaceutical company (TSX: TH, NASDAQ: THTX), announced its participation in two investor conferences this September. President and CEO Paul Lévesque will present at both events:
1. H.C. Wainwright 26th Annual Global Investment Conference (Sept. 9-11, 2024) at Lotte New York Palace Hotel. A virtual presentation will be available to attendees on Sept. 9.
2. 2024 Cantor Global Healthcare Conference (Sept. 17-19, 2024) at InterContinental Barclay Hotel, New York. Lévesque will participate in a fireside chat on Sept. 18 from 8:00-8:30 a.m. ET.
The management team will be available for one-on-one meetings during both conferences, providing opportunities for investors to engage directly with the company.
Theratechnologies, una compagnia biofarmaceutica (TSX: TH, NASDAQ: THTX), ha annunciato la sua partecipazione a due conferenze per investitori questo settembre. Il presidente e CEO Paul Lévesque presenterà a entrambi gli eventi:
1. H.C. Wainwright 26th Annual Global Investment Conference (9-11 settembre 2024) presso il Lotte New York Palace Hotel. Una presentazione virtuale sarà disponibile per i partecipanti il 9 settembre.
2. 2024 Cantor Global Healthcare Conference (17-19 settembre 2024) presso l'InterContinental Barclay Hotel, New York. Lévesque parteciperà a una discussione informale il 18 settembre dalle 8:00 alle 8:30 a.m. ET.
Il team di gestione sarà disponibile per incontri individuali durante entrambe le conferenze, offrendo opportunità agli investitori di interagire direttamente con la compagnia.
Theratechnologies, una empresa biofarmacéutica (TSX: TH, NASDAQ: THTX), anunció su participación en dos conferencias para inversores este septiembre. El presidente y CEO Paul Lévesque presentará en ambos eventos:
1. H.C. Wainwright 26th Annual Global Investment Conference (9-11 de septiembre de 2024) en el Lotte New York Palace Hotel. Una presentación virtual estará disponible para los asistentes el 9 de septiembre.
2. 2024 Cantor Global Healthcare Conference (17-19 de septiembre de 2024) en el InterContinental Barclay Hotel, Nueva York. Lévesque participará en una conversación informal el 18 de septiembre de 8:00 a 8:30 a.m. ET.
El equipo de gestión estará disponible para reuniones individuales durante ambas conferencias, brindando oportunidades a los inversores para interactuar directamente con la empresa.
Theratechnologies, 생명공학 제약 회사 (TSX: TH, NASDAQ: THTX),가 이번 9월 두 개의 투자자 회의에 참여한다고 발표했습니다. 사장 겸 CEO인 Paul Lévesque가 두 행사에서 발표할 예정입니다:
1. H.C. Wainwright 제26회 연례 세계 투자 회의 (2024년 9월 9-11일) Lotte New York Palace Hotel에서 개최됩니다. 9월 9일에 참가자들을 위한 가상 발표가 제공될 예정입니다.
2. 2024 Cantor Global Healthcare Conference (2024년 9월 17-19일) InterContinental Barclay Hotel, 뉴욕에서 개최됩니다. Lévesque는 9월 18일 오전 8시부터 8시 30분(ET)까지의 대화에 참여할 것입니다.
경영팀은 두 회의 기간 동안 개별 회의를 진행할 수 있도록 준비하고 있어 투자자들이 회사와 직접 교류할 수 있는 기회를 제공할 것입니다.
Theratechnologies, une entreprise biopharmaceutique (TSX: TH, NASDAQ: THTX), a annoncé sa participation à deux conférences pour investisseurs ce septembre. Le président et CEO Paul Lévesque présentera lors des deux événements :
1. H.C. Wainwright 26th Annual Global Investment Conference (9-11 septembre 2024) à l'Hôtel Lotte New York Palace. Une présentation virtuelle sera disponible pour les participants le 9 septembre.
2. 2024 Cantor Global Healthcare Conference (17-19 septembre 2024) à l'Hôtel InterContinental Barclay, New York. Lévesque participera à une discussion informelle le 18 septembre de 8h00 à 8h30 ET.
Le équipe de gestion sera disponible pour des rencontres individuelles pendant les deux conférences, offrant aux investisseurs l'opportunité d'interagir directement avec l'entreprise.
Theratechnologies, ein biopharmazeutisches Unternehmen (TSX: TH, NASDAQ: THTX), gab seine Teilnahme an zwei Investorenkonferenzen im September bekannt. Präsident und CEO Paul Lévesque wird bei beiden Veranstaltungen präsentieren:
1. H.C. Wainwright 26th Annual Global Investment Conference (9.-11. September 2024) im Lotte New York Palace Hotel. Eine virtuelle Präsentation wird den Teilnehmern am 9. September zur Verfügung stehen.
2. 2024 Cantor Global Healthcare Conference (17.-19. September 2024) im InterContinental Barclay Hotel, New York. Lévesque wird an einem informellen Gespräch am 18. September von 8:00 bis 8:30 Uhr ET teilnehmen.
Das Managementteam wird während beider Konferenzen für Einzelgespräche zur Verfügung stehen und Investoren die Möglichkeit bieten, direkt mit dem Unternehmen in Kontakt zu treten.
- None.
- None.
MONTREAL, Sept. 09, 2024 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and commercialization of innovative therapies, today announced that the Company’s President and CEO, Paul Lévesque will be presenting at two investor conferences in September. Members of the Theratechnologies management team will also be available for one-on-one meetings throughout the conferences.
| H.C. Wainwright 26th Annual Global Investment Conference | |
| Date: | September 9-11, 2024 |
| Location: | Lotte New York Palace Hotel |
| Presentation Details: | Virtual presentation accessible online to conference attendees on the morning of Monday, September 9, 2024 |
| 2024 Cantor Global Healthcare Conference | |
| Date: | September 17-19, 2024 |
| Location: | InterContinental Barclay Hotel, New York |
| Presentation Details: | Fireside chat on Wednesday, September 18 at 8:00-8:30 a.m. ET in Track 4, Empire Ballroom 1 |
About Theratechnologies
Theratechnologies (TSX: TH) (NASDAQ: THTX) is a biopharmaceutical company focused on the development and commercialization of innovative therapies addressing unmet medical needs. Further information about Theratechnologies is available on the Company's website at www.theratech.com, on SEDAR+ at www.sedarplus.ca and on EDGAR at www.sec.gov. Follow Theratechnologies on LinkedIn and X (formerly Twitter).
Contacts:
Investor inquiries:
Philippe Dubuc
Senior Vice President and Chief Financial Officer
pdubuc@theratech.com
1-438-315-6608
Media inquiries:
Julie Schneiderman
Senior Director, Communications & Corporate Affairs
communications@theratech.com
1-514-336-7800
FAQ
When and where is Theratechnologies (THTX) presenting at the H.C. Wainwright Global Investment Conference in September 2024?
What is the date and time of Theratechnologies' (THTX) presentation at the 2024 Cantor Global Healthcare Conference?
Who will be representing Theratechnologies (THTX) at the September 2024 investor conferences?
Will Theratechnologies (THTX) offer one-on-one meetings with investors at the September 2024 conferences?
